Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Clinical Pathology 2003;56:103-106; doi:10.1136/jcp.56.2.103
Copyright © 2003 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.
Journal of Clinical Pathology 2003;56:103-106
© 2003 BMJ Publishing Group & Association of Clinical Pathologists

ORIGINAL ARTICLE

Chymase expressing bone marrow mast cells in mastocytosis and myelodysplastic syndromes: an immunohistochemical and morphometric study

H-P Horny1, A Greschniok2, J-H Jordan4, D M Menke3 and P Valent4

1 Institute of Pathology, University of Lübeck, Ratzeburger Allee 160, D-23538 Lübeck, Germany
2 Institute of Pathology, University of Tübingen, Tübingen, Germany
3 Department of Pathology, Mayo Clinic Jacksonville, Florida, USA
4 Department of Internal Medicine I, Division of Hematology, University of Vienna, Vienna, Austria

Correspondence to:
Correspondence to:
Professor H-P Horny, Institute of Pathology, University of Lübeck, Ratzeburger Allee 160, D-23538 Lübeck, Germany;
horny{at}patho.mu-luebeck.de

Background: Two cell specific neutral proteases, tryptase and chymase, are produced by human mast cells (MC). Tryptase is constitutively expressed by all MC, whereas chymase is found only in an MC subset. Very little is known about chymase expression in MC proliferative disorders (mastocytosis).

Aims and Methods: Routinely processed, formalin fixed, and paraffin wax embedded bone marrow trephine biopsy specimens obtained from patients with various subtypes of mastocytosis (n = 47) and myelodysplastic syndromes (MDS; n = 28) were immunostained with antibodies against chymase and tryptase. Normal/reactive bone marrow specimens with intact haemopoiesis (n = 31) served as controls. The numbers of chymase expressing (C+) and of tryptase expressing (T+) MC were assessed morphometrically using a computer assisted video camera system.

Results: In normal/reactive bone marrow, the numbers of C+ MC (median, 8/mm2; maximum, 159/mm2) were in the same range as those of T+ MC (median, 4/mm2; maximum, 167/mm2). Because normal MC express both chymase and tryptase, these findings indicate that the common phenotype of bone marrow MC in normal/reactive states is MCTC (MC expressing both tryptase and chymase). In contrast, in MDS and mastocytosis, the bone marrow exhibited far more T+ MC than C+ MC in almost all cases.

Conclusions: According to these findings, the predominant MC type in the bone marrow in neoplastic states such as MDS and mastocytosis is MCT (MC expressing only tryptase). Although the pathophysiological basis of this apparent lack of chymase expression in most neoplastic MC in mastocytosis and MC involved in MDS remains unknown, this study has produced further evidence of the superior value of antitryptase antibodies in the diagnosis of mastocytosis.

Keywords: bone marrow; chymase; mast cell; mastocytosis; tryptase

Abbreviations: C+, chymase expressing; MC, mast cells; MCC, mast cells expressing only chymase; MCT, mast cells expressing only tryptase; MCTC, mast cells expressing both tryptase and chymase; MDS, myelodysplastic syndromes; T+, tryptase expressing


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Raymond, W. W., Su, S., Makarova, A., Wilson, T. M., Carter, M. C., Metcalfe, D. D., Caughey, G. H. (2009). {alpha}2-Macroglobulin Capture Allows Detection of Mast Cell Chymase in Serum and Creates a Reservoir of Angiotensin II-Generating Activity. J. Immunol. 182: 5770-5777 [Abstract] [Full Text]  
  • Krauth, M.T., Fodinger, M., Rebuzzi, L., Greul, R., Chott, A., Valent, P. (2007). Aggressive systemic mastocytosis with sarcoma-like growth in the skeleton, leukemic progression, and partial loss of mast cell differentiation antigens. haematol 92: e126-e129 [Full Text]  
  • Ozdemir, O, Savasan, S (2004). The role of mast cells in bone marrow diseases. J. Clin. Pathol. 57: 108-109 [Full Text]  

eLetters:

Read all eLetters

The Role of Mast Cells in Bone Marrow Diseases
Öner Özdemir, et al.
JCP Online, 31 Jul 2003 [Full text]

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs